PARIS – After experimental multiple sclerosis drug vatelizumab failed to meet its primary endpoints in a mid-stage trial, Sanofi AG (SNY) said it has dropped plans to develop the drug with India-based Glenmark Pharmaceuticals.   During a second-quarter results analysis with media members, Glenmark revealed that Sanofi was terminating the development agreement for vatelizumab, also […]

(Reuters Health) – Total knee replacement can usually relieve pain and improve function, but a nonsurgical regimen can also be effective in some people without posing the complication risks that can plague people who choose surgery, according to a new study. The test found that while 85 percent of patients who underwent surgery showed clinically-significant […]

Johnson & Johnson’s Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn’s disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine. Stelara, a biotech medicine that blocks inflammation, is approved to treat the skin condition […]

PARSIPPANY, N.J., Oct. 16, 2015 /PRNewswire/ — Daiichi Sankyo, Inc. (“the Company”) announced today that it will reorganize its U.S. Commercial organization as it begins to transition from a maturing primary care product portfolio to a differentiated specialty portfolio that will include areas such as cardiovascular, pain management and oncology.  “As we face the loss […]

Nestle is working with Lipid Therapeutics to develop and commercialize a new therapeutic treatment for mild-to-moderate ulcerative colitis, which can causes ulcers, bleeding and pain due to inflammation of the colon, the company said on Wednesday. Nestle Health Science intends to develop an add-on therapy to an existing one that is commonly used but with […]

STOCKHOLM–(BUSINESS WIRE)–Aerocrine (STO:AEROB) As previously announced, today is the last day of trading in the Aerocrine stock on Nasdaq Stockholm. Following completion of the recent public tender offer, Circassia Pharmaceuticals Plc (“Circassia”) has initiated a mandatory redemption procedure to acquire all shares not already held by Circassia. Further information on the redemption procedure will be […]

It sounds too good to be true. Shining red light on skin or cells in a dish gives an instant energy boost that could help heal wounds, relieve pain and perhaps help male infertility and other medical conditions. The curious healing effect has been known for decades – researchers have been investigating its use in […]

Middle-aged and older adults with torn cartilage or painful arthritis in their knee are not likely to benefit from so-called arthroscopic surgery, and could be harmed by it, a review of past studies suggests. Researchers reviewed nine previous studies with a combined 1,270 patients and found the surgery no better than other options like exercise […]

DUBLIN, IRELAND–(Marketwired – Jul 6, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced it has filed patent infringement lawsuits in the United States District Court for the District of New Jersey […]

Egalet Corp said data showed its experimental painkiller was less likely to be abused than a form of morphine already being sold. A study showed recreational opioid users did not like and were less prone to snort the company’s painkiller, Egalet-001, than MS Contin. Egalet’s study results come a week before a panel of experts […]